BIO Convention 2025 – Panel: The EU Policy Evolution and Revolution for Biotech

Name: BIO Convention 2025 – Panel: The EU Policy Evolution and Revolution for Biotech
Start: 2025-06-18T09:00:00+02:00
End: 2025-06-18T10:00:00+02:00

18 June @ 9:00 am – 10:00 am USA/Boston

Join EuropaBio in Boston for the key EU policy panel taking place at BIO 2025.

The EU is reshaping its biotechnology landscape, with the focus on competitiveness, supply and capacity resilience and societal benefit. A European Commission 5 year mandate has over 20 legislations and initiatives relevant to biotech and is an opportunity to both anchor and grow European innovation and create an attractive ecosystem for investment for global partners.

Speakers from across the European Commission will address the legislations that are the cornerstone of biotechnology performance, including the EU Biotech Act, General Pharmaceutical Legislation, Critical Medicines Act and others. These legislations aim to accelerate the growth of biotech to market and are underpinned by innovative funding models for industry from institutions such as the European Innovation Council.

Join the panel to find out how major legislative actions support innovation in the European Union and connect to the European Commission.

Moderator:

Claire Skentelbery, Director General EuropaBio

Speakers:

Carmen Laplaza Santos, Head of Unit Health Innovations and Ecosystems, DG RTD, European Commission
Giulia Del Brenna – Head of Unit – DG GROW, European Commission
Thomas Van Cangh – Deputy Head of Unit, DG Sante, European Commission
Denisa Perrin– Head of Unit, EIC Accelerator, European Innovation Council

More Info Here

Event Navigation

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.